Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein-Reference-Cited by-同舟云学术

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein

Published:2001-04 Issue:23-24 Volume:19 Page:3154-3163
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Yamada Tadanori,Iwabuki Hidehiko,Kanno Takashi,Tanaka Hiroyuki,Kawai Tomoji,Fukuda Hideki,Kondo Akihiko,Seno Masaharu,Tanizawa Katsuyuki,Kuroda Shun'ichi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Large surface proteins of hepatitis B virus containing the pre-s sequence;Heermann;J. Virol.,1984

2. Hepatitis B virus contains pre-S gene-encoded domains;Neurath;Nature,1985

3. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees;Itoh;Proc. Natl. Acad. Sci. USA,1986

4. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen;Milich;Science,1985

5. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region;Milich;Proc. Natl. Acad. Sci. USA,1985

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oriented immobilization of biomolecules on small surfaces;Biocatalyst Immobilization;2023

2. Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System;Pharmaceuticals;2021-04-25

3. Two-dimensional membrane scaffold for the oriented immobilization of biosensing molecules;Biosensors and Bioelectronics;2020-02

4. DDS Nanocarriers Mimicking Early Infection Machinery of Viruses;YAKUGAKU ZASSHI;2020-02-01

5. Carrier development for biopharmaceuticals: Bio-nanocapsules based on the early infection machinery of hepatitis B virus;Drug Delivery System;2020-01-25